Sinco Pharmaceuticals Holdings Limited

HKEX:6833.HK

0.184 (HKD) • At close November 5, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Omzet 1,526.8511,449.9371,090.1261,141.5791,129.9261,177.011847.0441,413.497636.306640.968535.441379.063573.894392.355414.368289.521569.373487.39608.681535.249414.83237.52
Kosten van de omzet 1,353.6391,279.203937.581,027.909937.728969.588689.5171,248.25527.727512.048444.514385.546464.261350.151388.252268.007486.319417.588525.976468.315351.994205.077
Brutowinst 173.212170.734152.546113.67192.198207.423157.527165.247108.579128.9290.927-6.483109.63342.20426.11621.51483.05469.80282.70566.93462.83632.443
Brutowinstmarge 0.1130.1180.140.10.170.1760.1860.1170.1710.2010.17-0.0170.1910.1080.0630.0740.1460.1430.1360.1250.1510.137
Onderzoek- en ontwikkelingskosten 13.46.7911.511.27026.1600.3690.4431.1980.3871.3970.6770.8981.0982.7462.3431.8311.1970.8210.9040
Algemene en administratieve kosten 61.18765.4342.51743.25737.32847.57517.42619.97420.14524.1721.00828.30727.1928.13629.1227.24335.17626.81913.70510.4537.0674.38
Verkoop- en marketingkosten 36.46846.61247.10149.24967.76770.50134.87428.50761.32970.06744.469150.275118.30184.80511.1149.412.063.1242.5853.9982.7941.698
Verkoop-, algemene en administratieve kosten 101.887114.14692.67493.398111.246120.5551.84650.38379.65590.56671.101179.533145.491112.94140.23436.65337.23629.94316.2914.4519.8616.078
Overige kosten 0000000000000000000-0.109-0.223-0.223
Bedrijfskosten 115.287120.937106.1590.45104.735123.36954.06255.19577.7698.1759.007200.215140.759177.38955.27733.18139.09938.13221.02217.77313.3615.855
Bedrijfsresultaat 57.92549.79756.27220.27280.95286.873105.681114.86428.92438.85619.324-180.042-36.969-70.737-14.118-15.13945.81839.85966.41552.48352.97522.319
Bedrijfsresultaat ratio 0.0380.0340.0520.0180.0720.0740.1250.0810.0450.0610.036-0.475-0.064-0.18-0.034-0.0520.080.0820.1090.0980.1280.094
Totaal overige inkomsten en kosten netto 10.0697.315-13.5030.452-2.384-11.17-13.997-9.0751.242-17.6912.466-40.6-14.404-88.414-21.5990.289-5.402-11.063-8.573-5.476-6.171.134
Inkomen voor belasting 67.99457.11242.76920.72478.56875.70391.684105.78930.16621.16521.79-220.642-51.373-159.151-35.717-14.8540.41628.79657.84247.00746.80523.453
Inkomen voor belasting ratio 0.0450.0390.0390.0180.070.0640.1080.0750.0470.0330.041-0.582-0.09-0.406-0.086-0.0510.0710.0590.0950.0880.1130.099
Belastingkosten 44.12434.35523.17413.18516.64515.90116.40320.1042.28612.8216.58411.2362.6364.7754.1962.6419.878.0549.1436.2447.4393.421
Nettowinst 23.8722.75719.5957.53961.92359.80275.28185.68532.4528.34515.207-231.878-48.736-154.376-31.52-11.69531.06220.91548.69935.17134.19620.032
Nettowinstmarge 0.0160.0160.0180.0070.0550.0510.0890.0610.0510.0130.028-0.612-0.085-0.393-0.076-0.040.0550.0430.080.0660.0820.084
WPA (Winst Per Aandeel) 0.0120.0110.010.0040.0310.0340.0450.0510.0190.0050.009-0.14-0.029-0.096-0.02-0.0070.0210.0170.0410.0290.0290.017
Verwaterde WPA 0.0120.0110.010.0040.0310.0340.0450.0510.0190.0050.009-0.14-0.029-0.096-0.02-0.0070.0210.0170.0410.0290.0290.017
EBITDA 78.61165.9861.36224.68684.32589.546108.145118.433.64643.47524.032-174.943-31.705-63.011-6.595-9.77151.04845.05171.45253.69253.64422.789
EBITDA ratio 0.0510.0460.0560.0220.0750.0760.1280.0840.0530.0680.045-0.462-0.055-0.161-0.016-0.0340.090.0920.1170.10.1290.096